| 1 |
35297512 | Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases. | 2022 Jun |
4 |
| 2 |
33165509 | Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients. | 2021 May 17 |
1 |
| 3 |
31721311 | The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development. | 2020 Jan |
3 |
| 4 |
27059729 | Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study. | 2016 Apr |
1 |
| 5 |
24342887 | Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. | 2014 Feb |
1 |